ICD-10 Coding for Cytosine Monophosphate Screening(D81.3, D81.3A, D81.3I)

Learn about cytosine monophosphate screening, its ICD-10 coding (Z13.29), and essential documentation requirements for accurate medical billing.

Also known as:
CMP ScreeningNucleotide Metabolism Screening
Related ICD-10 Code Ranges

Complete code families applicable to Cytosine Monophosphate Screening

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescription
Z13.29Encounter for screening for other metabolic disorders
E79.8Other disorders of purine and pyrimidine metabolism
D81.3Adenosine deaminase deficiency

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information

Essential facts and insights aboutCytosine Monophosphate Screening

Differential Codes

Alternative codes to consider when ruling out similar conditions

Metabolic disorder, unspecifiedE88.9

Use only if an abnormality is confirmed.

Documentation & Coding Risks

Avoid these common issues when documenting Cytosine Monophosphate Screening.

Vague documentation of screening results

Impact

Clinical: Inadequate information for clinical decision-making., Regulatory: Non-compliance with documentation standards., Financial: Potential denial of claims due to insufficient documentation.

Mitigation

Use specific quantitative results in documentation.

Using Z13.29 for confirmed metabolic disorders

Impact

Reimbursement: Incorrect reimbursement due to misclassification., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data on metabolic disorder prevalence.

Mitigation

Use specific codes like E79.8 or D81.3 for confirmed cases.

Screening Documentation

Impact

Lack of detailed test results in screening documentation.

Mitigation

Implement EHR alerts requiring numeric results for all metabolic screens.

Frequently Asked Questions